Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting

Background: Based on a retrospective study performed at our institution, 38% of inpatients living with human immunodeficiency virus (HIV) were found to have a medication error involving their anti-retroviral (ARV) and/or opportunistic infection (OI) prophylaxis medications. Objective: To determine...

Full description

Bibliographic Details
Main Authors: Chiampas TD, Biagi MJ, Badowski ME.
Format: Article
Language:English
Published: Centro de Investigaciones y Publicaciones Farmaceuticas 2019-09-01
Series:Pharmacy Practice
Subjects:
Online Access:https://pharmacypractice.org/journal/index.php/pp/article/view/1543
id doaj-a95c94a701634d2ca629dda7a3585df3
record_format Article
spelling doaj-a95c94a701634d2ca629dda7a3585df32020-11-25T02:59:16ZengCentro de Investigaciones y Publicaciones FarmaceuticasPharmacy Practice1885-642X1886-36552019-09-01173154310.18549/PharmPract.2019.3.1543 Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting Chiampas TDBiagi MJBadowski ME. Background: Based on a retrospective study performed at our institution, 38% of inpatients living with human immunodeficiency virus (HIV) were found to have a medication error involving their anti-retroviral (ARV) and/or opportunistic infection (OI) prophylaxis medications. Objective: To determine the impact of a dedicated HIV-trained clinical pharmacist on the ARV and OI prophylaxis medication error rates at our institution. Methods: A prospective quality improvement project was conducted over a six month period to assess the impact of a dedicated HIV-trained clinical pharmacist on the ARV and OI prophylaxis medication error rates. IRB approval received. Results: There were 144 patients included in this analysis, who experienced a combined 76 medication errors. Compared to historical control study conducted at our institution, the percent of patients who experienced a medication error remained stable (38% vs. 39%, respectively) and the error rate per patient was similar (1.44 vs. 1.36, p=NS). The percent of medication errors that were corrected prior to discharge increased from 24% to 70% and the median time to error correction decreased from 42 hours to 11.5 hours (p<0.0001). Conclusions: Errors relating to ARV or OI prophylaxis medications remain frequent in inpatient people living with HIV/AIDS. After multiple interventions were implemented, ARV and OI prophylaxis medication errors were corrected faster and with greater frequency prior to discharge, however, similar rates of errors for patients existed. Dedicated HIV clinicians with adequate training and credentialing are necessary to manage this specialized disease state and to reduce the overall number of medication errors associated with HIV/AIDS.https://pharmacypractice.org/journal/index.php/pp/article/view/1543Pharmacy Service HospitalPharmacistsMedication ErrorsQuality ImprovementAnti-Retroviral AgentsAcquired Immunodeficiency SyndromeHIV InfectionsInpatientsHistorically Controlled StudyIllinois
collection DOAJ
language English
format Article
sources DOAJ
author Chiampas TD
Biagi MJ
Badowski ME.
spellingShingle Chiampas TD
Biagi MJ
Badowski ME.
Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
Pharmacy Practice
Pharmacy Service Hospital
Pharmacists
Medication Errors
Quality Improvement
Anti-Retroviral Agents
Acquired Immunodeficiency Syndrome
HIV Infections
Inpatients
Historically Controlled Study
Illinois
author_facet Chiampas TD
Biagi MJ
Badowski ME.
author_sort Chiampas TD
title Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
title_short Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
title_full Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
title_fullStr Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
title_full_unstemmed Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
title_sort impact of an hiv-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
series Pharmacy Practice
issn 1885-642X
1886-3655
publishDate 2019-09-01
description Background: Based on a retrospective study performed at our institution, 38% of inpatients living with human immunodeficiency virus (HIV) were found to have a medication error involving their anti-retroviral (ARV) and/or opportunistic infection (OI) prophylaxis medications. Objective: To determine the impact of a dedicated HIV-trained clinical pharmacist on the ARV and OI prophylaxis medication error rates at our institution. Methods: A prospective quality improvement project was conducted over a six month period to assess the impact of a dedicated HIV-trained clinical pharmacist on the ARV and OI prophylaxis medication error rates. IRB approval received. Results: There were 144 patients included in this analysis, who experienced a combined 76 medication errors. Compared to historical control study conducted at our institution, the percent of patients who experienced a medication error remained stable (38% vs. 39%, respectively) and the error rate per patient was similar (1.44 vs. 1.36, p=NS). The percent of medication errors that were corrected prior to discharge increased from 24% to 70% and the median time to error correction decreased from 42 hours to 11.5 hours (p<0.0001). Conclusions: Errors relating to ARV or OI prophylaxis medications remain frequent in inpatient people living with HIV/AIDS. After multiple interventions were implemented, ARV and OI prophylaxis medication errors were corrected faster and with greater frequency prior to discharge, however, similar rates of errors for patients existed. Dedicated HIV clinicians with adequate training and credentialing are necessary to manage this specialized disease state and to reduce the overall number of medication errors associated with HIV/AIDS.
topic Pharmacy Service Hospital
Pharmacists
Medication Errors
Quality Improvement
Anti-Retroviral Agents
Acquired Immunodeficiency Syndrome
HIV Infections
Inpatients
Historically Controlled Study
Illinois
url https://pharmacypractice.org/journal/index.php/pp/article/view/1543
work_keys_str_mv AT chiampastd impactofanhivtrainedclinicalpharmacistinterventiononerrorratesofantiretroviralandopportunisticinfectionmedicationsintheinpatientsetting
AT biagimj impactofanhivtrainedclinicalpharmacistinterventiononerrorratesofantiretroviralandopportunisticinfectionmedicationsintheinpatientsetting
AT badowskime impactofanhivtrainedclinicalpharmacistinterventiononerrorratesofantiretroviralandopportunisticinfectionmedicationsintheinpatientsetting
_version_ 1724703372451250176